11.900
+0,00%
2026-10-05
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +38.2% | +102.7% | 2 / 3 | +47.6% | -0.48 pp | -0.76 pp | +8.0% | 0.25 | 12.03 | 297 | +47,6% | 33,1 | +38,2% | 12.03 | 21.85 | −44,9% |
| Pts | 8 | 12 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.900 (close price on 2026-10-05)EPS (TTM): 988,8
Financial charts
1.Revenue & growth
VND bn297Q2/26
1.Revenue & growth
VND bn297Q2/26
2.Profit & growth
VND bn33,1Q2/26
3.Profit mix (Penman)
VND bn130Q2/26
4.Margins & cost structure
%20.6%Q2/26
5.Returns & cash cycle
% · days5.9%Q2/26
6.Earnings quality & cash
VND bn-64,7Q2/26
7.Asset structure
VND bn1.897Q2/26
8.Funding & debt health
VND bn · times1.897Q2/26
9.Revenue backlog
VND bn68,7Q2/26
10.Valuation
times · %12,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %315Q2/26
Adjusted EPS growth, latest quarter
38.2%
Average adjusted EPS growth, 3 quarters
103%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26